Skip to main content

Clinical Research

Support Services

Comprehensive Solutions for Efficient Clinical Trials

Summit Clinical Research offers comprehensive services designed to facilitate the efficient conduct of clinical trials, addressing the critical aspects of site recruitment and participant motivation. Our network of well-connected MASH, Obesity, and Alzheimer’s investigator sites allows for a streamlined study initiation process and optimized enrollment timelines. By engaging fewer, yet high-performing sites, we aim to reduce the financial impacts of delays typical in the drug development process, potentially saving sponsors significant revenue. With tailored support and educational resources for sites, we strive to lower participant dropout rates and enhance the overall satisfaction of involved research personnel, promoting the high-quality collection of data without compromising on efficiency.

Precision Targeting
of Sites

Summit utilizes our trial database to analyze the sites’ performance on trials matching your protocol specifications.

Hitting the
Enrollment
Target

Summit works closely with the sites to provide tools such as digital marketing programs geared towards enrolling more patients.

Expedited Site
Start-Up

Streamlined workflow to create and distribute study-specific CDAs, feasibilities, and CTAs/budgets

Training
& Education

Provision of protocol training for sites and study teams, as well as KOL-led PI/CRC calls for best practice sharing.

Patient
Recruitement
& Retention

Tailoring retention to your patient population and study schedule. Summit’s recruitment starts with pre-screening and extends to external outreach.

Site
Motivation

Site motivation programs established to support the sites to reach their enrollment goals.

Total Summit Experience (Including Biopsy Proven NASH)
5,701
Total Rands Since 2019
22,336
Total Screens Since 2019
Summit Average Trial Contributions

% of Summit Sites Contributing to Trials

% of Rands from Summit Sites Contributing to Trials

Recent Success 2023-2024
Study A: Phase II, Bx proven MASH

<<Met target 4 months early and over enrolled by 100%>>

  • 40 enrollments contracted in 12 months
  • Completed in 8 months
  • 80 total enrolled
Study B: Phase IIa, Presumed MASH

<<Met target 3 months early and over enrolled by 75%>>

  • 40 enrollments contracted in 6 months
  • completed in 3 months
  • 70 total enrolled
Summit Sites Outperform Non-Summit Sites in Recruitment
Trial 1 MASH

% of Sites from Summit

12%

% of Screens from Summit

44%

% of Screens from Summit

44%
Trial 2 MASH

% of Sites from Summit

18%

% of Screens from Summit

44%

& of Rands from Summit sites

43%
Trial 3 Cirrhosis

% of Sites from Summit

12%

% of Screens from Summit

26%

& of Rands from Summit sites

25%

Interested in learning more about our clinical research support services?

Contact Us